San Diego, CA, United States of America

Suvi Orr


 

Average Co-Inventor Count = 10.8

ph-index = 2

Forward Citations = 6(Granted Patents)


Location History:

  • Old Saybrook, CT (US) (2016)
  • San Diego, CA (US) (2016 - 2018)

Company Filing History:


Years Active: 2016-2018

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Suvi Orr

Introduction

Suvi Orr is a pioneering inventor based in San Diego, California. With a remarkable portfolio boasting three patents, she is recognized for her significant contributions to the field of pharmaceutical innovations. Her work primarily focuses on developing effective treatments for cardiovascular conditions.

Latest Patents

Among her most notable inventions are two patents for 2-thiopyrimidinones, which serve as myeloperoxidase inhibitors. These pharmaceutical compositions are designed to offer potential therapeutic benefits in treating various cardiovascular conditions. Her research highlights the importance of innovative solutions in the medical field, providing new avenues for patient care.

Career Highlights

Suvi Orr is currently affiliated with Pfizer Corporation, a leading global pharmaceutical company. During her tenure, she has been instrumental in advancing research initiatives that lead to the development of breakthrough treatments. Her innovative spirit and dedication to science make her a valuable asset in her field.

Collaborations

Throughout her career, Suvi has collaborated with esteemed coworkers, including Philip Albert Carpino and David Hepworth. These partnerships have enriched her work, fostering a creative environment that encourages the sharing of ideas and expertise toward impactful innovations.

Conclusion

Suvi Orr exemplifies the essence of innovation in the pharmaceutical industry. Her patented inventions and collaborative efforts contribute to significant advancements in healthcare, particularly in tackling cardiovascular challenges. As she continues to explore new frontiers, her work remains a beacon of hope for improved patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…